Search hospitals > Minnesota > Minneapolis

Minneapolis Heart Institute Foundation

Claim this profile
Minneapolis, Minnesota 55407
Global Leader in Heart Failure
Global Leader in Coronary Artery Disease
Conducts research for Heart Attack
Conducts research for Cardiovascular Disease
Conducts research for Von Willebrand Disease
99 reported clinical trials
13 medical researchers
Photo of Minneapolis Heart Institute Foundation in MinneapolisPhoto of Minneapolis Heart Institute Foundation in MinneapolisPhoto of Minneapolis Heart Institute Foundation in Minneapolis

Summary

Minneapolis Heart Institute Foundation is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Heart Failure, Coronary Artery Disease, Heart Attack, Cardiovascular Disease, Von Willebrand Disease and other specialties. Minneapolis Heart Institute Foundation is involved with conducting 99 clinical trials across 177 conditions. There are 13 research doctors associated with this hospital, such as Santiago Garcia, MD, Paul Sorajja, MD, Jay Traverse, MD, and David Lin, Dr..

Top PIs

Clinical Trials running at Minneapolis Heart Institute Foundation

Heart Failure
Coronary Artery Disease
Cardiovascular Disease
Heart Disease
Tricuspid Valve Regurgitation
Tricuspid Valve Disease
Mitral Valve Regurgitation
Mitral Regurgitation
Aortic Regurgitation
Hypercholesterolemia
Image of trial facility.

Reprieve System

for Heart Failure

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Pulmonary Artery Sensor

for Heart Failure

This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordellaā„¢ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial). The study contains of 5 arms: NYHA II Cohort - To demonstrate safety and efficacy of the Cordella PA Sensor System in NYHA Class II HF patients, where patients have daily access to PAP data. * Treatment Arm (Group 1) * Active Control Arm (Group 2) * Crossover Arm (Group 3) NYHA III Cohort - To demonstrate safety and efficacy of the Cordella PA Sensor System in NYHA Class III HF patients, where patients have daily access to PAP data, including a randomized sub-study to evaluate a clinician-directed patient self-management strategy.
Recruiting1 award N/A10 criteria
Image of trial facility.

ICD

for Heart Failure

The investigators aim to compare the risk of mortality of Non-implantable carioverter defibrillator (ICD) vs. ICD management in patients with heart failure with reduced ejection fraction (HFrEF).
Recruiting1 award N/A1 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Minneapolis Heart Institute Foundation?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceĀ·Privacy PolicyĀ·CookiesĀ·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceĀ·Privacy PolicyĀ·CookiesĀ·Security